| Title : Neuroprotective Effects of Metformin and Berberine in Lipopolysaccharide-Induced Sickness-Like Behaviour in Mice - Kodi_2024_Adv.Pharmacol.Pharm.Sci_2024_8599268 |
| Author(s) : Kodi T , Praveen S , Paka SK , Sankhe R , Gopinathan A , Krishnadas N , Kishore A |
| Ref : Advances in Pharmacology Pharm Sci , 2024 :8599268 , 2024 |
| Abstract : |
| PubMedSearch : Kodi_2024_Adv.Pharmacol.Pharm.Sci_2024_8599268 |
| PubMedID: 39346967 |
| Title : Oxyresveratrol-beta-cyclodextrin mitigates streptozotocin-induced Alzheimer's model cognitive impairment, histone deacetylase activity in rats: in silico & in vivo studies - Agarwal_2024_Sci.Rep_14_9897 |
| Author(s) : Agarwal T , Manandhar S , B HK , Famurewa AC , Gurram PC , Suggala RS , Sankhe R , Mudgal J , Pai KSR |
| Ref : Sci Rep , 14 :9897 , 2024 |
| Abstract : |
| PubMedSearch : Agarwal_2024_Sci.Rep_14_9897 |
| PubMedID: 38688962 |
| Title : Oxyresveratrol-beta-cyclodextrin mitigates streptozotocin-induced Alzheimer's model cognitive impairment, histone deacetylase activity in rats: in silico & in vivo studies - Agarwal_2024_Sci.Rep_14_9897 |
| Author(s) : Agarwal T , Manandhar S , B HK , Famurewa AC , Gurram PC , Suggala RS , Sankhe R , Mudgal J , Pai KSR |
| Ref : Sci Rep , 14 :9897 , 2024 |
| Abstract : |
| PubMedSearch : Agarwal_2024_Sci.Rep_14_9897 |
| PubMedID: 38688962 |
| Title : Oxyresveratrol-beta-cyclodextrin mitigates streptozotocin-induced Alzheimer's model cognitive impairment, histone deacetylase activity in rats: in silico & in vivo studies - Agarwal_2024_Sci.Rep_14_9897 |
| Author(s) : Agarwal T , Manandhar S , B HK , Famurewa AC , Gurram PC , Suggala RS , Sankhe R , Mudgal J , Pai KSR |
| Ref : Sci Rep , 14 :9897 , 2024 |
| Abstract : |
| PubMedSearch : Agarwal_2024_Sci.Rep_14_9897 |
| PubMedID: 38688962 |
| Title : Neuroprotective Effects of Metformin and Berberine in Lipopolysaccharide-Induced Sickness-Like Behaviour in Mice - Kodi_2024_Adv.Pharmacol.Pharm.Sci_2024_8599268 |
| Author(s) : Kodi T , Praveen S , Paka SK , Sankhe R , Gopinathan A , Krishnadas N , Kishore A |
| Ref : Advances in Pharmacology Pharm Sci , 2024 :8599268 , 2024 |
| Abstract : |
| PubMedSearch : Kodi_2024_Adv.Pharmacol.Pharm.Sci_2024_8599268 |
| PubMedID: 39346967 |
| Title : Neuroprotective Effects of Metformin and Berberine in Lipopolysaccharide-Induced Sickness-Like Behaviour in Mice - Kodi_2024_Adv.Pharmacol.Pharm.Sci_2024_8599268 |
| Author(s) : Kodi T , Praveen S , Paka SK , Sankhe R , Gopinathan A , Krishnadas N , Kishore A |
| Ref : Advances in Pharmacology Pharm Sci , 2024 :8599268 , 2024 |
| Abstract : |
| PubMedSearch : Kodi_2024_Adv.Pharmacol.Pharm.Sci_2024_8599268 |
| PubMedID: 39346967 |
| Title : Beta-caryophyllene, a CB2R selective agonist, protects against cognitive impairment caused by neuro-inflammation and not in dementia due to ageing induced by mitochondrial dysfunction - Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| Author(s) : Kanojia U , Chaturbhuj SG , Sankhe R , Das M , Surubhotla R , Krishnadas N , Gourishetti K , Nayak PG , Kishore A |
| Ref : CNS Neurol Disord Drug Targets , : , 2021 |
| Abstract : |
| PubMedSearch : Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| PubMedID: 33530917 |
| Title : Beta-caryophyllene, a CB2R selective agonist, protects against cognitive impairment caused by neuro-inflammation and not in dementia due to ageing induced by mitochondrial dysfunction - Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| Author(s) : Kanojia U , Chaturbhuj SG , Sankhe R , Das M , Surubhotla R , Krishnadas N , Gourishetti K , Nayak PG , Kishore A |
| Ref : CNS Neurol Disord Drug Targets , : , 2021 |
| Abstract : |
| PubMedSearch : Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| PubMedID: 33530917 |
| Title : Beta-caryophyllene, a CB2R selective agonist, protects against cognitive impairment caused by neuro-inflammation and not in dementia due to ageing induced by mitochondrial dysfunction - Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| Author(s) : Kanojia U , Chaturbhuj SG , Sankhe R , Das M , Surubhotla R , Krishnadas N , Gourishetti K , Nayak PG , Kishore A |
| Ref : CNS Neurol Disord Drug Targets , : , 2021 |
| Abstract : |
| PubMedSearch : Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| PubMedID: 33530917 |